Elderly women battling breast cancer who have anxiety, depression or other mental health conditions are more likely to use opioids and more likely to die, a new study led by the University of Virginia School of Medicine has ...
Aug 23, 2019
0
7
A personalized approach to cancer treatment has become more common over the last several decades, with numerous targeted drugs approved to treat particular tumor types with specific mutations or patterns. However, this same ...
Aug 22, 2019
0
0
Every year, more than 250,000 women in the U.S. are diagnosed with breast cancer. When detected early, patients with the most common form—which tests positive for hormone receptors (HR+) and negative for the HER2 receptor—usually ...
Aug 22, 2019
0
11
Precision cancer medicine requires personalized biomarkers to identify patients who will benefit from specific cancer therapies. In an effort to improve the accuracy of predictions about prognosis for patients with breast ...
Aug 20, 2019
0
9
Pancreatic cancer is one of the deadliest cancers, with patients surviving on average less than a year once the disease has spread. There is an urgent need to evaluate more therapeutic targets. The chemotherapeutic agent ...
Aug 19, 2019
0
3
A new study by University of Kentucky researchers examines breast cancer survivors' experiences with communicating with their oncology team about employment and work issues.
Aug 19, 2019
0
8
Breast cancer is the leading cause of cancer-related death among women, and it is difficult to diagnose. Nearly 1 in 10 cancers is misdiagnosed as not cancerous; on the other hand, the more mammograms a woman has, the greater ...
Aug 16, 2019
0
9
A study from Vanderbilt-Ingram Cancer Center and the Department of Veterans Affairs led by Anna Vilgelm, MD, Ph.D., and Ann Richmond, Ph.D., has identified a possible second-line treatment for melanoma patients.
Aug 15, 2019
0
32
With the help of new technology, the researchers of the University of Turku in Finland have gained more detailed information on the diversity of the human lymphatic system than before. The research results can help to understand ...
Aug 13, 2019
0
1
BRCA1 and BRCA2 genetic variants are a clinically important risk factor for the development of ovarian and breast cancer, and women who carry these variants have a lifetime risk of ovarian cancer of 39%-44% and 11%-17%, respectively.
Aug 12, 2019
0
6
Breast cancer is a cancer that starts in the breast, usually in the inner lining of the milk ducts or lobules. There are different types of breast cancer, with different stages (spread), aggressiveness, and genetic makeup. With best treatment, 10-year disease-free survival varies from 98% to 10%. Treatment is selected from surgery, drugs (chemotherapy), and radiation. .
In the United States, there were 216,000 cases of invasive breast cancer and 40,000 deaths in 2004. Worldwide, breast cancer is the second most common type of cancer after lung cancer (10.4% of all cancer incidence, both sexes counted) and the fifth most common cause of cancer death. In 2004, breast cancer caused 519,000 deaths worldwide (7% of cancer deaths; almost 1% of all deaths).
Breast cancer is about 100 times as frequent among women as among men, but survival rates are equal in both sexes.
This text uses material from Wikipedia, licensed under CC BY-SA
